Oncotarget · 2017 · 38 citations · 29 references
MedicineCell BiologyOncologyMolecular OncologyNeuro-oncologyTumor ProgressionBrain TumorsCancer ProgressionMalignant NeoplasmsMalignant TumorsTumor InvasionChondroitin Sulfate BiosynthesisNeuroblastoma BiologyProteoglycans In CancerSphere Formation Assays
// Zhendong Su 1 , Satoshi Kishida 1 , Shoma Tsubota 1 , Kazuma Sakamoto 1 , Dongliang Cao 1 , Shinichi Kiyonari 1 , Miki Ohira 2 , Takehiko Kamijo 2 , Atsushi Narita 3 , Yinyan Xu 3 , Yoshiyuki Takahashi 3 and Kenji Kadomatsu 1 1 Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan 2 Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Saitama, Japan 3 Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan Correspondence to: Kenji Kadomatsu, email: kkadoma@med.nagoya-u.ac.jp Keywords: NCAN; CSPG; neuroblastoma; tumor sphere Received: July 14, 2017 Accepted: October 27, 2017 Published: November 15, 2017 ABSTRACT Neurocan (NCAN), a secreted chondroitin sulfate proteoglycan, is one of the major inhibitory molecules for axon regeneration in nervous injury. However, its role in cancer is not clear. Here we observed that high NCAN expression was closely associated with the unfavorable outcome of neuroblastoma (NB). NCAN was also highly and ubiquitously expressed in the early lesions and terminal tumor of TH- MYCN mice, a NB model. Interestingly, exogenous NCAN (i.e., overexpression, recombinant protein and conditioned medium) transformed adherent NB cells into spheres whose malignancies in vitro (anchorage-independent growth and chemoresistance) and in vivo (xenograft tumor growth) were potentiated. Both chondroitin sulfate sugar chains and NCAN's core protein were essential for the sphere formation. The CSG3 domain was essential in the moiety of NCAN. Our comprehensive microarray analysis and RT-qPCR of mRNA expression suggested that NCAN treatment promoted cell division, and urged cells to undifferentiated state. The knockdown of NCAN in tumor sphere cells cultured from TH- MYCN mice resulted in growth suppression in vitro and in vivo . Our findings suggest that NCAN, which stimulates NB cells to promote malignant phenotypes, is an extracellular molecule providing a growth advantage to cancer cells.
29
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.5K citations
Medicine, Oncology, Pharmacology +15
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson, Nirav R. Bhakta, Kai Kessenbrock et al. · Nature · 2015 · 925 citations · Full text
Targeted expression of MYCN causes neuroblastoma in transgenic mice
William A. Weiss, Gayatry Mohapatra, Burt G. Feuerstein et al. · The EMBO Journal · 1997 · 871 citations · Full text
PTPσ Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Yingjie Shen, Alan P. Tenney, Sarah A. Busch et al. · Science · 2009 · 681 citations · Full text